Despite potential benefits of joint ventures between dialysis companies and nephrologists, these arrangements raise legal and ethical concerns. And because of a lack of transparency, it is impossible to study whether these concerns are borne out in practice.
From the Perelman School of Medicine at the University of Pennsylvania (J.S.B., A.G., M.S.M.), and the Hospital of the University of Pennsylvania (J.S.B.) — both in Philadelphia.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.